Biophan Technologies 

Ticker: BIPH

Friday After the Bell: Boston Scientific and Biophan Expand R&D Relationship

Biophan Technologies announced that it has completed Phase I of a three-part joint development program with Boston Scientific (BSX). The program involves exploring the use of Biophan's cutting-edge, MRI safe and image compatible technologies with a variety of BSX products. The companies have already begun the next two phases, in which Biophan will receive additional payments and will extend BSX's first right to negotiate the licensing of Biophan technologies that result from the companies' joint development efforts.

To view the full Press Release please visit http://biz.yahoo.com/bw/040528/285265_1.html

Press Release: Biophan Announces Details of Study on Pacemaker Safety

Biophan is in discussions with several pacemaker manufacturers concerning adaptation of its technology in future pacemaker and defibrillator products. The study was performed to collect the information that will be needed by the manufacturers when they seek approval from the FDA to market an MRI-safe pacemaker.

To view the full Press Release please visit http://biz.yahoo.com/bw/040527/275293_1.html

Press Release: Biophan CEO Highlights Breakthrough Attributes of New Biothermal Battery

"Realizing the fact that a biothermal battery was now within striking distance because of major advances in thermoelectric materials, we worked with our board members on this acquisition. With the nanotechnology revolution under way, the ability to now put thousands and thousands of these small semi-conductor nodes that convert heat to electricity in the small space, perhaps the size of one or two postage stamps, has become feasible."

To view the full Press Release please visit http://biz.yahoo.com/bw/040520/205309_1.html

Media Article: Acquisition Activity Heats Up for MRI Imaging Industry

Biophan Technologies announced Friday that it acquired majority control of TE-Bio LLC. According to an 8-K filed with the Securities and Exchange Commission May 18, Biophan acquired 51% of TE-Bio LLC in exchange for committing $300,000 a year to research and development as well as sales support from Biophan's staff. No shares were issued for the acquisition.

To view the full Article please visit http://biz.yahoo.com/iw/040519/067589.html

To view the full report, including recent press releases and chart for BIPH please visit http://www.smallcapreview.com/biph.htm

Isonics Corporation 

Ticker: ISON

Press Release: Isonics Corporation Announces Initiative for Expansion of European Shareholder Base

Commenting on the pending campaign to expand awareness in Europe, James E. Alexander, Isonics' president and CEO said, "In today's somewhat volatile markets, it obviously helps to have as broad a shareholder base as possible, and we feel that we have a strong story to tell to the European investment community. We plan to use our existing presence as a springboard for several initiatives over the coming months to let foreign investors know who we are and what we do. Also, with recent tragic terrorist attacks in Europe, the fact that we are focused on developing products for explosive detection is a huge plus. We believe European investors will be very interested in Isonics and in our portfolio of products and technologies."

To view the full Article please visit http://biz.yahoo.com/bw/040526/265283_1.html

To view the full report, including recent press releases and chart for ISON please visit http://www.smallcapreview.com/Ison.htm

Disclaimer 

SmallCapReview.com feature stock reports are intended to be stock ideas, NOT recommendations. Please do your own research before investing. It is crucial that you at least look at current SEC filings and read the latest press releases. For continuing coverage of BIPH and ISON, please sign up for our free newsletter, SmallCapReview.com News. Information contained in this report was extracted from current documents filed with the SEC, the Company website and other publicly available sources deemed reliable. For more information see our disclaimer section, a link of which can be found on our website. This document contains forward-looking statements, particularly as related to the business plans of the Company, within the meaning of Section 27A of the Securities Act of 1933 and Sections 21E of the Securities Exchange Act of 1934, and are subject to the safe harbor created by these sections. Actual results may differ materially from the Company's expectations and estimates. This is an advertisement for the above mentioned companies. The purpose of this advertisement, like any advertising, is to provide coverage and awareness for the companies. The information provided in this advertisement is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject us to any registration requirement within such jurisdiction or country. 

Copyright SmallCapReview.com. All rights reserved. SmallCapReview.com is not a Registered Broker/Dealer or Financial Advisor, nor do we hold ourselves out to be. All materials presented on our website and individual reports released to the public through this website, e-mail or any other means of transmission are not to be regarded as investment advice and are only for informative purposes. Before making a purchase or sale of any securities featured on our website or mentioned in our reports, we strongly encourage and recommend consultation with a registered securities representative. This is not to be construed as a solicitation or recommendation to buy or sell securities. As with any stock, companies we select to profile involve a degree of investment risk and volatility, particularly Small-Caps and OTC-BB stocks. All investors are cautioned that they may lose all or a portion of their investment if they decide to make a purchase in any of our profiled companies. Past performance of our profiled stocks is not indicative of future results. The accuracy or completeness of the information on our website or within our reports is only as reliable as the sources they were obtained from. The profile and opinions expressed herein are expressed as of the date the profile is posted on site and are subject to change without notice. No investor should assume that reliance on the views, opinions or recommendations contained herein will produce profitable results. SmallCapReview.com may hold positions in securities mentioned herein, and may make purchases or sales in such securities featured on our website or within our reports. In order to be in full compliance with the Securities Act of 1933, Section 17(b), SmallCapReview.com will disclose in its disclaimer, what, if any compensation was received for our efforts in researching, presenting and disseminating this information to our subscriber database and featuring the report on the SmallCapReview.com website. SmallCapReview.com has been compensated eleven thousand dollars by a third party for its efforts in presenting the Biophan Technologies profile on its website and distributing it to its database of subscribers. SmallCapReview.com has been compensated eight thousand dollars by a third party for its efforts in presenting the Intelligent Business Systems Group profile on its website and distributing it to its database of subscribers. SmallCapReview.com has been compensated three thousand five hundred dollars by a third party for its efforts in presenting the Isonics Corporation profile on its website and distributing it to its database of subscribers. SmallCapReview.com may decide to purchase or sell shares on a voluntary basis in the open market before, during or after the profiling period of this report. Information presented on our website and within our reports contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be "forward looking statements." Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through the use of words such as ???expects??™???, ???will,??? ???anticipates,??? ???estimates, ???believes,??? or that by statements indicating certain actions ???may,??? ???could,??? or ???might??? occur. THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SMALL CAP SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. We encourage our readers to invest carefully and read the investor information available at the websites of the Securities and Exchange Commission (SEC) at: http://www.sec.gov and/or the National Association of Securities Dealers (NASD) at: http://www.nasd.com. Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its website.